Exosomes · Lesson 13 of 18 · 3 min

Exosomes for sexual wellness: what is the evidence?

Exosomes for erectile dysfunction and female sexual health rest on animal studies and case reports. No randomized controlled trials exist.

A gloved hand pipetting into small vials on a lab bench

Key takeaways.

  • Biological plausibility in this area significantly outpaces clinical validation.
  • Animal models of erectile dysfunction have shown functional improvement after exosome administration.
  • Human data are limited to case reports and small case series. No randomized controlled trials exist.
  • Erectile dysfunction trials show a 20 to 30 percent placebo response, so controls are essential.
  • The course treats this as an ethically sensitive application because patients may be vulnerable.
  • Exosomes are not FDA-approved for any sexual wellness use.

The clinical need

Sexual dysfunction is common and underreported. The Massachusetts Male Aging Study found that about 40 percent of men at age 40 have some degree of erectile difficulty, rising to 70 percent by age 70. Erectile dysfunction often accompanies cardiovascular disease.

Female sexual dysfunction covers disorders of desire, arousal, orgasm and sexual pain. It affects more than 40 percent of women at some point in life and has received far less research attention.

What the research consists of

For erectile dysfunction, the base is preclinical. Several research groups have reported functional improvement in animal models of diabetic, neurogenic and age-related erectile dysfunction after exosome administration.

In humans, there are case reports and small case series describing improvement on patient-reported questionnaires. No systematic pilot studies have been published, and no randomized controlled trials exist.

Why the lack of controls matters

Erectile dysfunction trials have a well-documented placebo response of 20 to 30 percent. Without a sham-controlled group, improvements reported in case series cannot be separated from expectation effects.

The course summary is that the science sounds convincing and animal studies look promising, but human evidence is essentially absent.

Ethics and regulation

Exosome therapies are not FDA-approved for therapeutic use. Any use in sexual wellness is investigational.

The course describes this as an ethically sensitive application. Patients may be distressed after failed conventional treatment, which raises the risk of false hope, financial harm, or forgoing treatments with established evidence.

Educational content for healthcare professionals. Not a treatment recommendation. Exosome therapies are not FDA-approved for therapeutic use.

Exosomes: 0 of 18 lessons finished

All lessons

This guide covers the what and the why.

The how is taught live. The webinar and live training go deeper on:

  • Evidence levels for each male and female application
  • Participant selection considerations
  • Informed consent for an investigational therapy
  • Ethical safeguards specific to sexual health

Common questions.

Are there clinical trials of exosomes for erectile dysfunction?
According to the course material, no randomized controlled trials have been published. Human evidence consists of case reports and small case series.
Are exosomes FDA-approved for sexual dysfunction?
No. Exosome therapies are not FDA-approved for any therapeutic use, including erectile dysfunction and female sexual health.
Why can case reports not show that a treatment works?
They have no control group. In erectile dysfunction, where placebo response is 20 to 30 percent, uncontrolled improvement cannot be attributed to the treatment.

Sources

  • Chen, F., et al. (2019). Adipose-derived mesenchymal stem cell-derived exosomes ameliorate erectile dysfunction in diabetic rats. International Journal of Molecular Medicine, 44(1), 51-60.
  • Ouyang, X., et al. (2018). Bone marrow mesenchymal stem cell-derived exosomes improve erectile dysfunction in rats. Andrologia, 50(8), e13041.
  • Zhu, G. Q., et al. (2020). Mesenchymal stem cell-derived exosomes alleviate erectile dysfunction in aging rats. Andrology, 8(2), 520-530.

Ready for the hands-on detail?

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.